Home > Research > Publications & Outputs > Impacts of COVID-19 lockdowns on frailty and we...

Links

Text available via DOI:

View graph of relations

Impacts of COVID-19 lockdowns on frailty and wellbeing in older people and those living with long-term conditions

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Impacts of COVID-19 lockdowns on frailty and wellbeing in older people and those living with long-term conditions. / Holland, C.; Garner, I.; Simpson, J. et al.
In: Advances in Clinical and Experimental Medicine , Vol. 30, No. 11, 25.11.2021, p. 1111-1114.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

APA

Vancouver

Holland C, Garner I, Simpson J, Eccles F, Pardo EN, Marr C et al. Impacts of COVID-19 lockdowns on frailty and wellbeing in older people and those living with long-term conditions. Advances in Clinical and Experimental Medicine . 2021 Nov 25;30(11):1111-1114. doi: 10.17219/acem/144135

Author

Holland, C. ; Garner, I. ; Simpson, J. et al. / Impacts of COVID-19 lockdowns on frailty and wellbeing in older people and those living with long-term conditions. In: Advances in Clinical and Experimental Medicine . 2021 ; Vol. 30, No. 11. pp. 1111-1114.

Bibtex

@article{5b032f490ead41cb85f6916d68d5c6c8,
title = "Impacts of COVID-19 lockdowns on frailty and wellbeing in older people and those living with long-term conditions",
abstract = "Lockdowns and social distancing have been important and successful strategies to limit the spread of the coronavirus disease 2019 (COVID-19) virus. However, excess deaths related to non-COVID-19 causes have been reported, suggesting issues around availability and use of health services, particularly for people with conditions needing ongoing medical support. In addition, evidence indicates that a range of age-related diseases and frailty are impacted by physical activity and social engagement, both limited in lockdown situations. It is therefore important to learn from the effects of lockdowns in order to limit any impacts, while still protecting people from the infection. This editorial summarizes two research themes at the Centre for Ageing Research at Lancaster University in the UK, one assessing impacts of lockdown for people living with a long-term neurodegenerative condition, Parkinson's disease, and one assessing longitudinal impacts on frailty and wellbeing, with older adults aged over 70, including those living with at least one long-term condition. Uncertainty related to Parkinson's disease and to COVID-19 amplified each other, and cancelled clinical appointments and limitations on physical activity had very significant impacts on wellbeing for this group. In the longitudinal study, frailty was more severe during lockdown periods. While lockdowns reduce spread of the virus, becoming frailer could make older adults more vulnerable to the effects of the virus during these periods. Regular exercise during lockdown had beneficial effects aiding recovery once restrictions relaxed. These studies suggest factors that could lessen negative impacts of future lockdowns. Maintaining physical activity and providing access to health services during periods of lockdown are suggested as priorities.",
keywords = "aged, COVID-19, frailty, Parkinson{\textquoteright}s disease, physical distancing, communicable disease control, human, longitudinal study, Aged, Communicable Disease Control, Frailty, Humans, Longitudinal Studies, SARS-CoV-2",
author = "C. Holland and I. Garner and J. Simpson and F. Eccles and E.N. Pardo and C. Marr and S. Varey",
year = "2021",
month = nov,
day = "25",
doi = "10.17219/acem/144135",
language = "English",
volume = "30",
pages = "1111--1114",
journal = "Advances in Clinical and Experimental Medicine ",
issn = "2451-2680",
publisher = "Wroclaw Medical University Press",
number = "11",

}

RIS

TY - JOUR

T1 - Impacts of COVID-19 lockdowns on frailty and wellbeing in older people and those living with long-term conditions

AU - Holland, C.

AU - Garner, I.

AU - Simpson, J.

AU - Eccles, F.

AU - Pardo, E.N.

AU - Marr, C.

AU - Varey, S.

PY - 2021/11/25

Y1 - 2021/11/25

N2 - Lockdowns and social distancing have been important and successful strategies to limit the spread of the coronavirus disease 2019 (COVID-19) virus. However, excess deaths related to non-COVID-19 causes have been reported, suggesting issues around availability and use of health services, particularly for people with conditions needing ongoing medical support. In addition, evidence indicates that a range of age-related diseases and frailty are impacted by physical activity and social engagement, both limited in lockdown situations. It is therefore important to learn from the effects of lockdowns in order to limit any impacts, while still protecting people from the infection. This editorial summarizes two research themes at the Centre for Ageing Research at Lancaster University in the UK, one assessing impacts of lockdown for people living with a long-term neurodegenerative condition, Parkinson's disease, and one assessing longitudinal impacts on frailty and wellbeing, with older adults aged over 70, including those living with at least one long-term condition. Uncertainty related to Parkinson's disease and to COVID-19 amplified each other, and cancelled clinical appointments and limitations on physical activity had very significant impacts on wellbeing for this group. In the longitudinal study, frailty was more severe during lockdown periods. While lockdowns reduce spread of the virus, becoming frailer could make older adults more vulnerable to the effects of the virus during these periods. Regular exercise during lockdown had beneficial effects aiding recovery once restrictions relaxed. These studies suggest factors that could lessen negative impacts of future lockdowns. Maintaining physical activity and providing access to health services during periods of lockdown are suggested as priorities.

AB - Lockdowns and social distancing have been important and successful strategies to limit the spread of the coronavirus disease 2019 (COVID-19) virus. However, excess deaths related to non-COVID-19 causes have been reported, suggesting issues around availability and use of health services, particularly for people with conditions needing ongoing medical support. In addition, evidence indicates that a range of age-related diseases and frailty are impacted by physical activity and social engagement, both limited in lockdown situations. It is therefore important to learn from the effects of lockdowns in order to limit any impacts, while still protecting people from the infection. This editorial summarizes two research themes at the Centre for Ageing Research at Lancaster University in the UK, one assessing impacts of lockdown for people living with a long-term neurodegenerative condition, Parkinson's disease, and one assessing longitudinal impacts on frailty and wellbeing, with older adults aged over 70, including those living with at least one long-term condition. Uncertainty related to Parkinson's disease and to COVID-19 amplified each other, and cancelled clinical appointments and limitations on physical activity had very significant impacts on wellbeing for this group. In the longitudinal study, frailty was more severe during lockdown periods. While lockdowns reduce spread of the virus, becoming frailer could make older adults more vulnerable to the effects of the virus during these periods. Regular exercise during lockdown had beneficial effects aiding recovery once restrictions relaxed. These studies suggest factors that could lessen negative impacts of future lockdowns. Maintaining physical activity and providing access to health services during periods of lockdown are suggested as priorities.

KW - aged

KW - COVID-19

KW - frailty

KW - Parkinson’s disease

KW - physical distancing

KW - communicable disease control

KW - human

KW - longitudinal study

KW - Aged

KW - Communicable Disease Control

KW - Frailty

KW - Humans

KW - Longitudinal Studies

KW - SARS-CoV-2

U2 - 10.17219/acem/144135

DO - 10.17219/acem/144135

M3 - Journal article

VL - 30

SP - 1111

EP - 1114

JO - Advances in Clinical and Experimental Medicine

JF - Advances in Clinical and Experimental Medicine

SN - 2451-2680

IS - 11

ER -